Enhancing Gamma Band Response in Schizophrenia to Improve Working Memory
Enhancing Gamma Band Response in Schizophrenia to Improve Working Memory
批准号:
10165824
负责人:
Fiza Singh
金额:
$50.21万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2023-04-30
关键词:
AffectAftercareAmericanAreaAttentionBase of the BrainBindingBrain DiseasesChronicCognitiveCognitive deficitsCommunitiesComputersDataDoseDouble-Blind MethodEffectivenessElectroencephalographyExhibitsHourImpairmentIndependent LivingIndividualInterventionMeasurementMeasuresMediatingMediator of activation proteinMental disordersNeuronsOutcomePatientsPhasePilot ProjectsPlacebosPlayProtocols documentationRandomizedRefractoryResearch DesignRoleSchizophreniaSeveritiesShort-Term MemorySurveysSymptomsTestingTimeTrainingWorkbasecognitive functioncosteconomic impactfeasibility testingfunctional outcomesimprovedmultisensoryneural networkneurofeedbacknew therapeutic targetnovelnovel therapeuticsopen labelprimary outcomerelating to nervous systemrepetitive transcranial magnetic stimulationresponsesecondary outcomeskillssocietal costs
中文摘要
摘要
精神分裂症(SCZ)是一种慢性衰弱性精神障碍,影响240万美国人,
这将导致相当大的个人和社会成本。在SCZ患者中,认知缺陷(CD)发生在
疾病的过程,与更严重的疾病有关,是功能性疾病的最佳预测因子。
结果。尽管如此,迄今为止,CD一直难以使用可用的治疗方法治疗。最近的研究
提示SCZ患者的CD可能是由分布式神经网络的异常同步引起的。
神经元的同步或同步放电,将皮层区域绑定到任务中的功能网络中,
国家依赖的方式。因此,改善异常神经同步的新疗法可能会改善
以前由大脑网络紊乱引起的难治性症状。
伽马波段(GBR,30- 45 Hz)的神经同步在自上而下的注意力中起着核心作用,
多感觉加工、知觉联结和工作记忆。SCZ患者表现出异常
GBR,并且损害的程度与认知紊乱的严重程度相关。鉴于这些
结果:改善GBR应改善CD,包括SCZ的WM。这一假设已经过检验,
重复经颅磁刺激(rTMS)。此外,基于EEG的神经反馈
(NFB)被假设可以改善SCZ患者的GBR和认知功能。NFB是一种低成本,
给予和耐受良好的治疗。在健康对照组中,Gamma-NFB改善了GBR和认知功能,
功能包括WM。因此,我们建议测试的可行性和有效性,提高GBR使用
使用R61/R33机制的框架在SCZ患者中使用γ-NFB。
第一项试验(R61)是一项概念验证研究,旨在评估靶点参与和剂量
响应曲线30名SCZ患者将接受20周的G-NFB训练(每周2次,每次30分钟
持续时间),并评估1)培训证据,2)GBR变化,3)WM变化和4)
社区功能。第二次试验(R33)旨在确认基于训练的目标接合
从R61获得的参数,并评估G-NFB是否上级活性安慰剂神经反馈
干预改善GBR、WM和社区功能。
英文摘要
ABSTRACT
Schizophrenia (SCZ) is a chronic debilitating mental disorder that affects 2.4 million Americans and
leads to considerable individual and societal costs. In patients with SCZ, cognitive deficits (CD) occur early in
the course of the illness, are associated with more severe illness, and are the best predictor of functional
outcomes. Nonetheless, to date, CD have been difficult to treat using available treatments. Recent studies
suggest CD in patients with SCZ may arise from abnormal synchronization of distributed neural networks.
Synchronization or synchronous firing of neurons, binds cortical areas into functional networks in a task and
state-dependent manner. Thus novel therapies that improve abnormal neural synchrony may improve
previously refractory symptoms arising from disordered brain networks.
Neural synchrony in the gamma band (GBR, 30-45Hz) plays a central role in top-down attention,
multisensory processing, perceptual binding and working memory (WM). Patients with SCZ exhibit abnormal
GBR, and the magnitude of impairment is associated with the severity of cognitive disorganization. Given these
results, improving GBR should improve CD, including WM in SCZ. This hypothesis has been tested and
confirmed using repetitive transcranial magnetic stimulation (rTMS). Additionally, EEG-based neurofeedback
(NFB) is hypothesized to improve GBR and cognitive function in patients with SCZ. NFB is a low-cost, easily
administered and well-tolerated treatment. In healthy controls, Gamma-NFB improves GBR and cognitive
function including WM. Thus, we propose testing the feasibility and effectiveness of improving GBR using
gamma-NFB in patients with SCZ using the framework of the R61/R33 mechanism.
The first trial (R61) is a proof-of-concept study designed to assess target engagement and dose
response curve. Thirty SCZ patients will receive G-NFB training for 20 weeks (2 weekly sessions of 30minute
duration) and be assessed for 1) evidence of training, 2) Change in GBR, 3) Change in WM and 4) Change in
community functioning. The second trial (R33) aims to confirm target engagement based on training
parameters obtained from R61, and to assess whether G-NFB is superior to an active-placebo neurofeedback
intervention in improving GBR, WM and community functioning.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancing Gamma Band Response in Schizophrenia to Improve Working Memory
-
批准号:10793826
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2023
-
负责人:Fiza Singh
-
依托单位:
Enhancing gamma band response to improve working memory in individuals with mild cognitive impairment
-
批准号:10599955
-
项目类别:
-
资助金额:$65.37万
-
财政年份:2020
-
负责人:Fiza Singh
-
依托单位:
Enhancing gamma band response to improve working memory in individuals with mild cognitive impairment
-
批准号:10370329
-
项目类别:
-
资助金额:$67.31万
-
财政年份:2020
-
负责人:Fiza Singh
-
依托单位:
Enhancing Gamma Band Response in Schizophrenia to Improve Working Memory
-
批准号:9817085
-
项目类别:
-
资助金额:$9.76万
-
财政年份:2019
-
负责人:Fiza Singh
-
依托单位:
Enhancing Gamma Band Response in Schizophrenia to Improve Working Memory
-
批准号:10412010
-
项目类别:
-
资助金额:$45.68万
-
财政年份:2017
-
负责人:Fiza Singh
-
依托单位:
海外基金